Once-daily LABA/ICS combined inhalers versus inhaled long-acting beta2-agonists for people with chronic obstructive pulmonary disease

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess the effectiveness and safety of once-daily LABA/ICS in a combined inhaler versus once/twice-daily LABA for the treatment of COPD.

This is a protocol.

Health topics:

Published:

29 February 2016

Authors:

Hidalgo M P, Celis CA, Rico M, Rojas-Reyes MX, Dennis RJ, Beijers R

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Hidalgo M P, Celis CA, Rico M, Rojas-Reyes MX, Dennis RJ, Beijers R. Once-daily LABA/ICS combined inhalers versus inhaled long-acting beta2-agonists for people with chronic obstructive pulmonary disease (Protocol). Cochrane Database of Systematic Reviews 2016, Issue 2. Art. No.: CD012100. DOI: 10.1002/14651858.CD012100.